US2023042445A1PendingUtilityA1

Use of mitochondria to promote wound repair and/or wound healing

72
Assignee: TAIWAN MITOCHONDRION APPLIED TECH CO LTDPriority: Mar 20, 2020Filed: Mar 19, 2021Published: Feb 9, 2023
Est. expiryMar 20, 2040(~13.6 yrs left)· nominal 20-yr term from priority
Inventors:Han-Chung ChengChih-Kai HsuHui-Ching Tseng
A61K 38/00A61K 35/28A61K 35/19A61K 35/14A61K 35/16C12N 2500/80C12N 5/0646C12N 5/0634C12N 5/0662A61P 19/04A61K 35/12A61P 13/12A61P 19/02C12N 5/0667A61K 38/36A61P 43/00C12N 2500/84C12N 2502/115A61P 17/14A61M 1/029C12N 2501/998A61P 17/18A61P 21/00C12N 5/0605A61M 1/3693A61P 17/02C12N 5/0018G01N 33/6893A61K 9/0053A61K 9/0019
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention discloses a use of mitochondria to promote wound repair and/or healing. Specifically, when a certain amount of mitochondria or a composition containing a certain amount of mitochondria is administered to a wound, the effect of promoting wound repair or accelerating wound healing can be effectively achieved.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition, comprising a mitochondria and a blood product, wherein the blood product comprises at least one growth factor. 
     
     
         2 . The composition of  claim 1 , wherein the blood product is a platelet-rich fibrin (PRF). 
     
     
         3 . The composition of  claim 1 , wherein the dose of the mitochondria ranges from 1 µg to 80 ug. 
     
     
         4 . A use of mitochondria to prepare a composition for repairing wounds or promoting wound healing. 
     
     
         5 . The use of mitochondria to prepare a composition for repairing wounds or promoting wound healing of  claim 4 , wherein the composition further comprises a platelet-rich fibrin (PRF). 
     
     
         6 . The use of mitochondria to prepare a composition for repairing wounds or promoting wound healing of  claim 4 , wherein the dose of the mitochondria ranges from 1 µg to 80 µg. 
     
     
         7 . A use of mitochondria to prepare a composition for promoting tissue regeneration. 
     
     
         8 . The use of mitochondria to prepare a composition for promoting tissue regeneration of  claim 7 , wherein the composition further comprises a platelet-rich fibrin (PRF). 
     
     
         9 . The use of mitochondria to prepare a composition for promoting tissue regeneration of  claim 7 , wherein the dose of the mitochondria ranges from 1 µg to 80 ug.

Join the waitlist — get patent alerts

Track US2023042445A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.